Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ayrshire Capital Management John Nevin Jr. | 44,335 | $5,039,103 | +16% | 2.72% |
| 2. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 11,400 | $1,295,724 | 0.53% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.50 | 2,040 | 7,296 | 2021-02-23 | Filing | ||
| $73.40 | 2,000 | Officer | 52,562 | 2019-04-22 | Filing | |
| $72.32 | 100 | Director | 6,400 | 2019-01-31 | Filing | |
| $72.31 | 100 | Director | 6,300 | 2019-01-31 | Filing | |
| $72.33 | 1,800 | Director | 6,200 | 2019-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $118.50 | 963 | 125,697 | 2024-03-01 | Filing | ||
| $118.50 | 801 | 62,968 | 2024-03-01 | Filing | ||
| $118.50 | 676 | 91,260 | 2024-03-01 | Filing | ||
| $118.50 | 472 | 18,760 | 2024-03-01 | Filing | ||
| $118.50 | 694 | 84,314 | 2024-03-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 156,444,700 | $17,219,868,129 | 0.37% | |
| 2. | 134,064,516 | $14,756,481,316 | 0.37% | |
| 3. | 86,588,614 | $9,530,825,115 | 2.34% | |
| 4. | 74,687,176 | $8,220,817,462 | 0.39% | |
| 5. | 64,294,784 | $7,077,147,935 | 1.58% |
News See All
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Abbott's First Quarter 2024 Earnings Conference Call.
Jim Cramer is Recommending These 5 Stocks in April
This article presents an overview of Jim Cramer is Recommending These 5 Stocks in April. For a detailed overview of such stocks, read our article, Jim Cramer is Recommending These 10 Stocks in April...
Jim Cramer's 5 Favorite Healthcare Stock Picks in 2024
This article presents an overview of Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. For a detailed overview of such stocks, read our article, Jim Cramer’s 10 Favorite Healthcare Stock...
5 Magnificent Dividend Growth Stocks to Buy and Hold Forever
This article presents an overview of 5 Magnificent Dividend Growth Stocks to Buy and Hold Forever. For a detailed overview of such stocks, read our article, 11 Magnificent Dividend Growth Stocks ...
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
16 Most Undervalued Large Cap Stocks To Buy According To Analysts
In this article, we will be taking a look at the 16 most undervalued large-cap stocks to buy according to analysts.
15 Highest Paying Countries for Biomedical Engineers
In this article, we will look at the 15 highest paying countries for biomedical engineers. We have also discussed the global bioengineering technology market.
10 Undervalued Dividend Aristocrats To Buy According to Analysts
In this article, we discuss 10 undervalued dividend aristocrats to buy according to analysts.
5 Dividend Kings To Invest In For Safe Dividend Growth
In this article, we discuss 5 dividend kings to invest in for safe dividend growth.
Billionaire Hedge Funds
